• Accelerating action on cervical screening in lower- and middle-income countries (LMICs) post COVID-19 era. Preventive Medicine.
• Health care provider perspectives on cervical screening for Aboriginal and Torres Strait Islander women: a qualitative study. ANZJPH.
• Australian National Cervical Screening Program Renewal: attitudes and experiences of General Practitioners, and Obstetricians and Gynaecologists​. Aust NZ J Obstet Gynaecol.
• Surveillance systems for monitoring cervical cancer elimination efforts: focus on HPV infection, cervical dysplasia, cervical screening and treatment. Prev Med.
• Current and future vaccine clinical research with the licensed 2-, 4-, and 9-valent VLP HPV vaccines: What’s ongoing, what’s needed? Prev Med.
• Immunology of HPV Infection and Vaccination: Progress and Challenges. Frontiers in Immunology.
• Human Papillomavirus Vaccination After COVID-19. JNCI Cancer Spectrum.
• Achieving cervical cancer elimination among Indigenous women. Prev Med.
• Impact and cost-effectiveness of strategies to accelerate cervical cancer elimination: A model-based analysis. Prev Med.
• Human Papillomavirus Vaccination for Adults Aged 30-45 Years in the United States: A Cost-Effectiveness Analysis. PLoS Med.
• Impact of COVID-19-related care disruptions on cervical cancer screening in the United States. J Med Screen.
• Elimination of cervical cancer in Tanzania: Modelled analysis of elimination in the context of endemic HIV infection and active HIV control. Int J Cancer.
• Active surveillance as a management option for cervical intraepithelial neoplasia 2: an online randomised experimental study. Gynecologic Oncology.